Boehringer Can Hide Emails In FTC Pay-For-Delay Suit

A D.C. federal judge found Tuesday that Boehringer Ingelheim Pharmaceuticals is protected by attorney-client privilege from disclosing the majority of subpoenaed financial documents in the Federal Trade Commission's pay-for-delay suit over...

Already a subscriber? Click here to view full article